vs
Side-by-side financial comparison of PERRIGO Co plc (PRGO) and UNISYS CORP (UIS). Click either name above to swap in a different company.
PERRIGO Co plc is the larger business by last-quarter revenue ($1.1B vs $574.5M, roughly 1.9× UNISYS CORP). UNISYS CORP runs the higher net margin — 3.3% vs -127.8%, a 131.1% gap on every dollar of revenue. On growth, UNISYS CORP posted the faster year-over-year revenue change (5.3% vs -2.5%). PERRIGO Co plc produced more free cash flow last quarter ($148.6M vs $97.3M). Over the past eight quarters, UNISYS CORP's revenue compounded faster (8.5% CAGR vs 1.3%).
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...
Unisys Corporation is a technology company founded in 1986 and headquartered in Blue Bell, Pennsylvania. The company provides cloud, AI, digital workplace, logistics, and enterprise computing services.
PRGO vs UIS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.1B | $574.5M |
| Net Profit | $-1.4B | $18.7M |
| Gross Margin | 32.6% | 33.9% |
| Operating Margin | -116.0% | 13.3% |
| Net Margin | -127.8% | 3.3% |
| Revenue YoY | -2.5% | 5.3% |
| Net Profit YoY | -3093.9% | -37.7% |
| EPS (diluted) | $-10.23 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.1B | $574.5M | ||
| Q3 25 | $1.0B | $460.2M | ||
| Q2 25 | $1.1B | $483.3M | ||
| Q1 25 | $1.0B | $432.1M | ||
| Q4 24 | $1.1B | $545.4M | ||
| Q3 24 | $1.1B | $497.0M | ||
| Q2 24 | $1.1B | $478.2M | ||
| Q1 24 | $1.1B | $487.8M |
| Q4 25 | $-1.4B | $18.7M | ||
| Q3 25 | $7.5M | $-308.9M | ||
| Q2 25 | $-8.4M | $-20.1M | ||
| Q1 25 | $-6.4M | $-29.5M | ||
| Q4 24 | $-44.4M | $30.0M | ||
| Q3 24 | $-21.0M | $-61.9M | ||
| Q2 24 | $-108.4M | $-12.0M | ||
| Q1 24 | $2.0M | $-149.5M |
| Q4 25 | 32.6% | 33.9% | ||
| Q3 25 | 36.1% | 25.5% | ||
| Q2 25 | 34.4% | 26.9% | ||
| Q1 25 | 37.6% | 24.9% | ||
| Q4 24 | 33.9% | 32.1% | ||
| Q3 24 | 37.2% | 29.2% | ||
| Q2 24 | 37.0% | 27.2% | ||
| Q1 24 | 33.1% | 27.9% |
| Q4 25 | -116.0% | 13.3% | ||
| Q3 25 | 7.0% | -7.3% | ||
| Q2 25 | 4.3% | 6.3% | ||
| Q1 25 | 4.5% | 1.2% | ||
| Q4 24 | 10.0% | 8.9% | ||
| Q3 24 | 7.4% | 1.5% | ||
| Q2 24 | -2.5% | 4.9% | ||
| Q1 24 | -5.1% | 3.6% |
| Q4 25 | -127.8% | 3.3% | ||
| Q3 25 | 0.7% | -67.1% | ||
| Q2 25 | -0.8% | -4.2% | ||
| Q1 25 | -0.6% | -6.8% | ||
| Q4 24 | -3.9% | 5.5% | ||
| Q3 24 | -1.9% | -12.5% | ||
| Q2 24 | -10.2% | -2.5% | ||
| Q1 24 | 0.2% | -30.6% |
| Q4 25 | $-10.23 | $0.24 | ||
| Q3 25 | $0.05 | $-4.33 | ||
| Q2 25 | $-0.06 | $-0.28 | ||
| Q1 25 | $-0.05 | $-0.42 | ||
| Q4 24 | $-0.32 | $0.45 | ||
| Q3 24 | $-0.15 | $-0.89 | ||
| Q2 24 | $-0.79 | $-0.17 | ||
| Q1 24 | $0.01 | $-2.18 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $413.9M |
| Total DebtLower is stronger | — | $729.0M |
| Stockholders' EquityBook value | $2.9B | $-282.6M |
| Total Assets | $8.5B | $1.8B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $413.9M | ||
| Q3 25 | $432.1M | $321.9M | ||
| Q2 25 | $454.2M | $300.8M | ||
| Q1 25 | $409.9M | $393.1M | ||
| Q4 24 | $558.8M | $376.5M | ||
| Q3 24 | $1.5B | $373.7M | ||
| Q2 24 | $542.8M | $344.9M | ||
| Q1 24 | $658.5M | $382.8M |
| Q4 25 | — | $729.0M | ||
| Q3 25 | — | $723.2M | ||
| Q2 25 | — | $692.7M | ||
| Q1 25 | — | $488.3M | ||
| Q4 24 | — | $488.2M | ||
| Q3 24 | — | $488.5M | ||
| Q2 24 | — | $489.2M | ||
| Q1 24 | — | $488.4M |
| Q4 25 | $2.9B | $-282.6M | ||
| Q3 25 | $4.4B | $-300.2M | ||
| Q2 25 | $4.5B | $-221.5M | ||
| Q1 25 | $4.4B | $-267.8M | ||
| Q4 24 | $4.3B | $-283.4M | ||
| Q3 24 | $4.6B | $-202.2M | ||
| Q2 24 | $4.5B | $-174.1M | ||
| Q1 24 | $4.7B | $-158.6M |
| Q4 25 | $8.5B | $1.8B | ||
| Q3 25 | $10.1B | $1.7B | ||
| Q2 25 | $10.1B | $1.8B | ||
| Q1 25 | $9.8B | $1.8B | ||
| Q4 24 | $9.6B | $1.9B | ||
| Q3 24 | $11.2B | $1.9B | ||
| Q2 24 | $10.4B | $1.9B | ||
| Q1 24 | $10.6B | $1.9B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $175.4M | $104.9M |
| Free Cash FlowOCF − Capex | $148.6M | $97.3M |
| FCF MarginFCF / Revenue | 13.4% | 16.9% |
| Capex IntensityCapex / Revenue | 2.4% | 1.3% |
| Cash ConversionOCF / Net Profit | — | 5.61× |
| TTM Free Cash FlowTrailing 4 quarters | $145.1M | $-170.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $175.4M | $104.9M | ||
| Q3 25 | $51.7M | $38.0M | ||
| Q2 25 | $75.9M | $-316.2M | ||
| Q1 25 | $-64.5M | $33.3M | ||
| Q4 24 | $312.6M | $76.6M | ||
| Q3 24 | $42.2M | $32.0M | ||
| Q2 24 | $9.5M | $2.7M | ||
| Q1 24 | $-1.4M | $23.8M |
| Q4 25 | $148.6M | $97.3M | ||
| Q3 25 | $29.8M | $32.4M | ||
| Q2 25 | $56.7M | $-324.1M | ||
| Q1 25 | $-90.0M | $24.4M | ||
| Q4 24 | $274.9M | $66.5M | ||
| Q3 24 | $15.1M | $25.2M | ||
| Q2 24 | $-18.9M | $-6.0M | ||
| Q1 24 | $-26.5M | $17.1M |
| Q4 25 | 13.4% | 16.9% | ||
| Q3 25 | 2.9% | 7.0% | ||
| Q2 25 | 5.4% | -67.1% | ||
| Q1 25 | -8.6% | 5.6% | ||
| Q4 24 | 24.2% | 12.2% | ||
| Q3 24 | 1.4% | 5.1% | ||
| Q2 24 | -1.8% | -1.3% | ||
| Q1 24 | -2.4% | 3.5% |
| Q4 25 | 2.4% | 1.3% | ||
| Q3 25 | 2.1% | 1.2% | ||
| Q2 25 | 1.8% | 1.6% | ||
| Q1 25 | 2.4% | 2.1% | ||
| Q4 24 | 3.3% | 1.9% | ||
| Q3 24 | 2.5% | 1.4% | ||
| Q2 24 | 2.7% | 1.8% | ||
| Q1 24 | 2.3% | 1.4% |
| Q4 25 | — | 5.61× | ||
| Q3 25 | 6.89× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 2.55× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -0.70× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
UIS
Segment breakdown not available.
